Avro is a life sciences company, located in Canada and founded in 2016 by Shakir Lakhani and Keean Waterloo, Ontario, that makes skin patches capable of delivering generic drugs.
January 4, 2018
Avro finished its seed funding round on January 4, 2018 raising $120,000 in funding from Y Combinator.
Avro finished its seed funding round on January 4, 2018 raising $120,000 in funding from Y Combinator.